Selective N-type voltage sensitive calcium channel (VSCC) blockers have sho
wn utility in several models of stroke amid pain. We are especially interes
ted in small molecule N-type calcium channel blockers for therapeutic use.
Herein, we report a series of N,N-dialkyl-dipeptidylamines with potent func
tional activity at N-type VSCCs and in vivo efficacy. The synthesis, SAR, a
nd pharmacological evaluation of this series are discussed. (C) 1999 Elsevi
er Science Ltd. All rights reserved.